CannaMed Panama, S.A. began operations in 2019 (incorporated in 2020) with the intent of becoming a vertically integrated medical cannabis company, headquartered in Panama.  Upon legalization, the company plans to serve the legal medical cannabis market with a focus on the cultivation and production of bulk cannabis flower and extracts.

Updated 8/28/2021:  The Panamanian National Assembly approved Bill 153 in the second debate on 8/26/2021, indicating there will be seven licenses issued.  CannaMed Panama will actively pursue one of these license, but makes no representations that it will receive one.


© 2021 CannaMed Panama – ALL RIGHTS RESERVED